… Daniel Dorgan … Daniel Dorgan … Olivier KN, Eagle G, McGinnis JP II, Micioni L, Daley CL,
Winthrop KL, Ruoss S, Addrizzo-Harris DJ, Flume P, Dorgan D, et al. Randomized, double-blind, …

BACKGROUND Several molecular imaging strategies can identify bacterial infections in
humans. PET affords the potential for sensitive infection detection deep within the body. Among …

Background Chronic rhinosinusitis (CRS) is very prevalent in the cystic fibrosis (CF) patient
population, and leads to high morbidity and markedly decreased quality of life (QOL). …

Background The clinical effects of Aspergillus fumigatus in the cystic fibrosis (CF) airway,
with the exception of allergic bronchopulmonary aspergillosis, is unclear. Methods CF …

Rationale The clinical significance of Aspergillus fumigatus (Af) detection in the absence of
allergic bronchopulmonary aspergillosis in cystic fibrosis (CF) airways remains unclear. Yet, …

A Diagnostic Sequence A 42-year-old woman presented to the ED with a 3-day history of
shortness of breath, fatigue, and cough productive of thick, yellow-green sputum. She also …

Keywords: cystic fibrosis; CFTR modulator; elexacaftor; tezacaftor; ivacaftor; chronic
rhinosinusitis; sinus surgery; SNOT-22 EN cystic fibrosis CFTR modulator elexacaftor tezacaftor …

Aminoglycosides are commonly used to treat infections in CF patients and are highly
ototoxic. The incidence of tobramycin-induced hearing loss, tinnitus, vertigo or dizziness (ototoxicity…

Background The respiratory tract fungal microbiome in cystic fibrosis (CF) has been understudied
despite increasing recognition of fungal pathogens in CF lung disease. We sought to …

Background Rapidly growing mycobacteria (RGM) have high rates of intrinsic antibiotic
resistance and require prolonged antibiotic therapies associated with considerable toxicity. Less …